Abstract:<p class="a-plus-plus">Raising a heterologous tier 2 neutralizing antibody (nAb) response remains a daunting task for HIV vaccine development. In this study, we explored the utility of diverse HIV-1 envelope (Env) immunogens in a sequential immunization scheme as a solution to this task. This exploration stemmed from the rationale that gp145, a membrane-bound truncation form of HIV Env, may facilitate the focusing of induced antibody response on neutralizing epitopes when sequentially combined with the soluble gp140 form as immunogens in a prime-boost mode. We first showed that gp140 DNA prime-gp145 Tiantan vaccinia (TV) boost likely represents a general format for inducing potent nAb response in mice. However, when examined in rhesus macaque, this modality showed little effectiveness. To improve the efficacy, we extended the original modality by adding a strong protein boost, namely native-like SOSIP.664 trimer displayed on ferritin-based nanoparticle (NP), which was generated by a newly developed click approach. The resulting three-immunization regimen succeeded in eliciting tier-2 nAb response with substantial breadth when implemented in rhesus macaque over a short 8-week schedule. Importantly, the elicited nAb response was able to effectively contain viremia upon a heterologous SHIV challenge. Collectively, our studies highlighted that diversification of Env immunogens, in both types and formulations, under the framework of a sequential immunization scheme might open new opportunity toward HIV vaccine development.</p>

Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires.

Vaccination Induces Maturation of Diverse Unmutated VRC01-class Precursors to HIV-1 Broadly Neutralizing Antibodies in an Ig-humanized Mouse Model

Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth

Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

Initiation of HIV Neutralizing B Cell Lineages with Sequential Envelope Immunizations

Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates

Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques

Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies

Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responses.

Initiation of Immune Tolerance–controlled HIV Gp41 Neutralizing B Cell Lineages

Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice

Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site

Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimer

E108 Analysis of Broad Neutralizing B Cell Lineages to Guide HIV-1 Immunogen Design

Vaccination induces HIV broadly neutralizing antibody precursors in humans

Staged Induction of HIV-1 Glycan–dependent Broadly Neutralizing Antibodies

Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans

Neutralization Takes Precedence over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection.

Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction

Exploration of a Sequential Gp140-Gp145 Immunization Regimen with Heterologous Envs to Induce a Protective Cross-Reactive HIV Neutralizing Antibody Response In Non-human Primates